AQUALIS:QoL of CLL patients treated with acalabrutinib in France, retrospective study based on data from PLATON database

Trial Identifier: D8220R00057
Sponsor: AstraZeneca
Collaborator:
Hospitalidee
Hospitalidee has been asserted to be a valid organization name by UHToulouse
Start Date: April 2025
Primary Completion Date: December 2025
Study Completion Date: December 2025
Condition: CLL (Chronic Lymphocytic Leukemia)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France Saint-Affrique, France